TNDM vs. DXCM
Compare and contrast key facts about Tandem Diabetes Care, Inc. (TNDM) and DexCom, Inc. (DXCM).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TNDM or DXCM.
Correlation
The correlation between TNDM and DXCM is 0.43, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
TNDM vs. DXCM - Performance Comparison
Loading data...
Key characteristics
TNDM:
-0.77
DXCM:
-0.58
TNDM:
-0.93
DXCM:
-0.40
TNDM:
0.87
DXCM:
0.92
TNDM:
-0.55
DXCM:
-0.52
TNDM:
-1.31
DXCM:
-0.84
TNDM:
39.80%
DXCM:
39.31%
TNDM:
67.98%
DXCM:
58.70%
TNDM:
-99.25%
DXCM:
-94.61%
TNDM:
-92.42%
DXCM:
-46.59%
Fundamentals
TNDM:
$1.54B
DXCM:
$33.52B
TNDM:
-$2.79
DXCM:
$1.33
TNDM:
0.00
DXCM:
1.32
TNDM:
1.56
DXCM:
8.08
TNDM:
9.90
DXCM:
14.79
TNDM:
$1.10B
DXCM:
$4.15B
TNDM:
$513.31M
DXCM:
$2.46B
TNDM:
-$150.68M
DXCM:
$889.80M
Returns By Period
In the year-to-date period, TNDM achieves a -36.90% return, which is significantly lower than DXCM's 11.82% return. Over the past 10 years, TNDM has underperformed DXCM with an annualized return of -15.21%, while DXCM has yielded a comparatively higher 17.61% annualized return.
TNDM
-36.90%
34.82%
-20.97%
-51.95%
-31.91%
-23.22%
-15.21%
DXCM
11.82%
26.82%
14.02%
-33.80%
2.69%
-2.75%
17.61%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
TNDM vs. DXCM — Risk-Adjusted Performance Rank
TNDM
DXCM
TNDM vs. DXCM - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Tandem Diabetes Care, Inc. (TNDM) and DexCom, Inc. (DXCM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
TNDM vs. DXCM - Dividend Comparison
Neither TNDM nor DXCM has paid dividends to shareholders.
Drawdowns
TNDM vs. DXCM - Drawdown Comparison
The maximum TNDM drawdown since its inception was -99.25%, roughly equal to the maximum DXCM drawdown of -94.61%. Use the drawdown chart below to compare losses from any high point for TNDM and DXCM. For additional features, visit the drawdowns tool.
Loading data...
Volatility
TNDM vs. DXCM - Volatility Comparison
Tandem Diabetes Care, Inc. (TNDM) has a higher volatility of 21.05% compared to DexCom, Inc. (DXCM) at 17.10%. This indicates that TNDM's price experiences larger fluctuations and is considered to be riskier than DXCM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
TNDM vs. DXCM - Financials Comparison
This section allows you to compare key financial metrics between Tandem Diabetes Care, Inc. and DexCom, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TNDM vs. DXCM - Profitability Comparison
TNDM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Tandem Diabetes Care, Inc. reported a gross profit of 118.41M and revenue of 234.42M. Therefore, the gross margin over that period was 50.5%.
DXCM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, DexCom, Inc. reported a gross profit of 589.00M and revenue of 1.04B. Therefore, the gross margin over that period was 56.9%.
TNDM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Tandem Diabetes Care, Inc. reported an operating income of -120.88M and revenue of 234.42M, resulting in an operating margin of -51.6%.
DXCM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, DexCom, Inc. reported an operating income of 133.70M and revenue of 1.04B, resulting in an operating margin of 12.9%.
TNDM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Tandem Diabetes Care, Inc. reported a net income of -130.56M and revenue of 234.42M, resulting in a net margin of -55.7%.
DXCM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, DexCom, Inc. reported a net income of 105.40M and revenue of 1.04B, resulting in a net margin of 10.2%.